Potent delivery of functional proteins into Mammalian cells in vitro and in vivo using a supercharged protein
about
A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivoIntracellular targeting with engineered proteinsGetting in shape: controlling peptide bioactivity and bioavailability using conformational constraintsRole of molecular charge in nucleocytoplasmic transportBiodegradable double nanocapsule as a novel multifunctional carrier for drug delivery and cell imagingDiscovery and characterization of smORF-encoded bioactive polypeptidesArginine residues are more effective than lysine residues in eliciting the cellular uptake of onconase.Direct delivery of functional proteins and enzymes to the cytosol using nanoparticle-stabilized nanocapsulesInternalization by multiple endocytic pathways and lysosomal processing impact maspin-based therapeutics.Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivoImproved assays for determining the cytosolic access of peptides, proteins, and their mimetics.Development of a functional antibody by using a green fluorescent protein frame as the templateRegeneration of hyaline-like cartilage in situ with SOX9 stimulation of bone marrow-derived mesenchymal stem cells.Coordinate lentiviral expression of Cre recombinase and RFP/EGFP mediated by FMDV 2A and analysis of Cre activity.Zebrabow: multispectral cell labeling for cell tracing and lineage analysis in zebrafish.Intracellular nucleic acid delivery by the supercharged dengue virus capsid proteinA protein therapeutic modality founded on molecular regulation.Direct protein delivery to mammalian cells using cell-permeable Cys2-His2 zinc-finger domains.Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.Delivery of antibody mimics into mammalian cells via anthrax toxin protective antigenProtein delivery using Cys2-His2 zinc-finger domains.Interaction of nucleic acids with the glycocalyxCellular uptake mechanisms and endosomal trafficking of supercharged proteins.Investigating endogenous peptides and peptidases using peptidomicsGene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure.Advanced materials and processing for drug delivery: the past and the future.Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.Anthrax toxin-mediated delivery of the Pseudomonas exotoxin A enzymatic domain to the cytosol of tumor cells via cleavable ubiquitin fusions.Antibody-mediated neutralization of perfringolysin o for intracellular protein delivery.Scratching the Surface: Resurfacing Proteins to Endow New Properties and Function.Discovery and characterization of a new cell-penetrating protein.Cre Fused with RVG Peptide Mediates Targeted Genome Editing in Mouse Brain Cells In VivoAn Evolved RNA Recognition Motif That Suppresses HIV-1 Tat/TAR-Dependent Transcription.Nucleic acid-mediated intracellular protein delivery by lipid-like nanoparticles.Tailoring nanocarriers for intracellular protein delivery.Comparative analysis of the methods of drug and protein delivery for the treatment of cancer, genetic diseases and diagnostics.Cell-penetrating peptides: A tool for effective delivery in gene-targeted therapies.Getting across the cell membrane: an overview for small molecules, peptides, and proteins.A Biotin Ligase-Based Assay for the Quantification of the Cytosolic Delivery of Therapeutic Proteins.DNA-Mediated Cellular Delivery of Functional Enzymes.
P2860
Q24619754-641F0A89-0DE2-4C4D-98F7-F7780309DAADQ26740106-62DFC4B1-6019-4F03-824C-C3FBB025840DQ27021652-865B914E-66DD-4A40-A582-27F6C70E2FB0Q27321906-651B0E78-AAE2-49E0-80E1-51C055316034Q28397490-00FD26D2-F9A0-49F7-BD99-8EB13F2DEE09Q28829292-8095836A-B99A-4282-8763-2BECFB80DAF9Q30407943-9D442308-E1C9-4F53-81DD-80AB68471945Q30543833-86CE15D7-91D3-4C25-A3C1-73C39799FD1AQ30594122-3A91634B-1C3D-469B-8390-7922AF5F8550Q30614255-46DCD5FB-1B10-41A1-BC42-D25F0DE56AEAQ33553611-E7A66F61-CECE-47B1-A47A-B53034905C6DQ33798870-0294CB1D-F6DE-43C6-92E0-ED26AF413A7BQ33860082-675F47AC-7292-4933-9D91-812D7766F7DAQ34244585-D74A3BE9-2F8A-49A7-A585-B885018FBCCBQ34350239-B9299B78-96D6-4A93-9591-9870280C0322Q35067517-AF96D6E5-A057-4C66-BA0E-35C2F6DDC0F9Q35239717-F6274527-67C3-493D-B158-3A092759AC0DQ35461043-9E62A1A0-035D-47F4-907B-2BD154565689Q35684362-4BFFD4E4-596E-43CC-9DE7-205F8E2CE1D8Q35838335-463F5959-6DD6-4802-811B-1A62F46E11F8Q35900519-CA5DEDD4-1AE6-447D-8CA8-79E79D62AB4BQ35964883-4A4C1830-C041-4EE7-8151-461894CE7551Q36129709-AE028DE3-2C93-469A-AB0A-ED5BA217F348Q36163374-3929E05F-6506-40EB-8B35-A67684FDBEA1Q36438289-FC3F16E7-0A82-437E-9466-FAABC44B9DE8Q36589333-56DF148E-8437-4388-9144-A55F4DDB9596Q36710629-B1CBC123-4A35-4CA5-A41A-8835346AF24CQ36829224-E8984956-4D2C-4A26-BF37-DEC5603117DCQ36926959-ADA8FD45-A304-4B43-A65F-BB1A3ADF339DQ36945870-0470352B-907E-4CFE-A6B6-425ABB0342C2Q37407912-E277F40B-1E64-49FC-B78A-42AD1BFB4E21Q37534848-96D905FB-5E80-47F2-8778-BBC8F3623F38Q37544898-93C1E86C-8357-40A2-8447-0CCDB63582BDQ37602237-82A342CE-4233-4594-9104-47863CEA7913Q37874945-76F74319-67CA-4F89-88E9-8DF892B18F66Q37921774-1A3A3229-2521-4F62-8A7E-80F6B2DC84ECQ38198590-5B66B8DA-CE23-4254-835C-CBF0C72AE669Q38307864-C12FD091-8E2A-488A-9F82-6FD1C514ABFDQ38751257-BF8EF82C-1A6C-4390-A5A0-8419E3F5FBE9Q38818127-78AC41EE-D0EA-4B12-9911-4046BBA66A44
P2860
Potent delivery of functional proteins into Mammalian cells in vitro and in vivo using a supercharged protein
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Potent delivery of functional ...... o using a supercharged protein
@ast
Potent delivery of functional ...... o using a supercharged protein
@en
Potent delivery of functional ...... o using a supercharged protein
@nl
type
label
Potent delivery of functional ...... o using a supercharged protein
@ast
Potent delivery of functional ...... o using a supercharged protein
@en
Potent delivery of functional ...... o using a supercharged protein
@nl
prefLabel
Potent delivery of functional ...... o using a supercharged protein
@ast
Potent delivery of functional ...... o using a supercharged protein
@en
Potent delivery of functional ...... o using a supercharged protein
@nl
P2093
P2860
P3181
P356
P1433
P1476
Potent delivery of functional ...... o using a supercharged protein
@en
P2093
Brian R McNaughton
Constance L Cepko
David B Thompson
David R Liu
James J Cronican
P2860
P304
P3181
P356
10.1021/CB1001153
P407
P577
2010-08-01T00:00:00Z